The objective of this study was to examine the therapeutic efficacy of EGT in a psoriasis model and to elucidate the underlying mechanisms of action of EGT in reducing phosphorylated NF-κB and JAK/STAT3 expression. The gene discussed is NFKB1; the disease is psoriasis.